Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
November 8, 2025INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENTOpen Access

Enhancing the Patient Safety by using the Explainable Artificial Intelligence in Pharmacovigilance

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMegha Rani RaigondSGS. Ganesh

Discussion

Loading...

Member takes

Overview

Artificial intelligence identifies adverse drug reactions in patient data, suggesting improved drug safety outcomes.

Key Points

  • Adverse drug reactions were identified using artificial intelligence techniques, enhancing patient safety.
  • The model achieved an accuracy of 82% in predicting side effects from patient data.
  • Analysis leverages the Health Improvement Network database to extract drug interaction data.
  • Improvements in pharmacovigilance may reduce drug withdrawals and support public health initiatives.

Cite This Study

Raigond et al. (2025) studied this question.

synapsesocial.com/papers/690e8b75a5b062d7a4e738dbhttps://doi.org/10.55041/ijsrem53455
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool2025 · 26 citations
  2. 2In situ development of an artificial intelligence (AI) model for early detection of adverse drug reactions (ADRs) to ensure drug safety2025
  3. 3Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration2025 · 40 citations
  4. 4A scoping review of the application of artificial intelligence for the analysis of adverse drug events in clinical research2025
  5. 5Beyond black boxes: using explainable causal artificial intelligence to separate signal from noise in pharmacovigilance2025 · 6 citations